Date: 15.10.2015
DÜSSELDORF, Germany and LONDON, Oct. 15, 2015 (GLOBE NEWSWIRE) - On 17th October, 3 pm Ekso Bionics will give a presentation on exoskeletons in neurological rehabilitation at the expert forum Marktplatz Gehirn at REHACARE exhibition (14.-17.October) in Düsseldorf. At the specialized exhibition area for patients with traumatic brain injury (hall 3, booth 2F39), Marco Sauer, Area Sales Manager, Ekso Bionics, will speak on how gait training with Ekso GT bionic exoskeleton may help patients after stroke or traumatic brain injury to walk earlier in their rehabilitation phase and to potentially improve their motor skills. He is supported by his colleague and physiotherapist Sebastian Stallasch who will complement the presentation with practical insights into Ekso assisted neurorehabilitation.
In Germany more than 1 million people are forced to live with the effects of stroke or traumatic brain injury. In handling their everyday lives, most of them depend heavily on help and assistance of other people. The expert forum "Marktplatz Gehirn" is organized by ZNS - Hannelore Kohl Stiftung and the specialist printer HW-Studio Weber provides affected patients, their relatives as well as physicians, therapists and nursing auxiliary with a communication platform for exchange of information on new therapies, rehabilitation measures and medical aids.
Ekso Bionics is aware of the importance of effective therapeutic measures in rehabilitation of stroke patients and traumatic brain injury patients. The "wearable" exoskeleton Ekso GT offers affected individuals who suffer lower extremity paralysis or weakness optimal gait training and helps them re-learn proper step patterns and weight shifts. Ekso's unique feature, SmartAssist, allows the patients to contribute any amount of their own power, which can be adjusted dynamically and in real-time to the patient's performance.
"For patients who are left paralyzed or restricted in walking after stroke or traumatic brain injury, the restoration of their mobility is an essential component of their rehabilitation," says Marco Sauer. "Ekso GT enables the patients not only to potentially start earlier with their gait training but also to take more. Furthermore, Ekso GT also relieves the physiotherapists as during the gait training, the full weight of the patient is borne by the gait robotic and not by the therapist."
More Information on Ekso Bionics can be found at www.eksobionics.com
Twitter (@EksoBionicsDE)
Facebook (www.facebook.com/eksobionics)
YouTube (http://www.youtube.com/user/EksoBionics/ ) .
About Ekso Bionics
Since 2005, Ekso Bionics has been a leader in the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable. Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO.
CONTACT:
Press Contact: Ekso Bionics Marco Sauer, Area Sales Manager (EU)
Tel. +49 89 5506 7774
E-Mail: MSauer@eksobionics.com
Web: www.eksobionics.com
Press Contact: Weissenbach PR Dorothea Keck, Bastian Schink
Tel. +49 89 5506 7773
E-Mail: ekso@weissenbach-pr.de
Web: www.weissenbach-pr.de
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Cancer cells - Czech Scientists are Working to Find the Achilles†Heel of Cancer Cells
Nature Biotechnology - Biotechnology at Nature.com server.
Tea brews up silver nanoparticles for wound healing in the developing world
Antioxidant carbon dot nanozymes alleviate depression in rats by restoring the gut microbiome